Targeting Inflammatory Pathways in Atherosclerosis: Exploring New Opportunities for Treatment
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
1 Online-Ressource.
- Sprache
-
Englisch
- Erschienen in
-
Targeting Inflammatory Pathways in Atherosclerosis: Exploring New Opportunities for Treatment ; volume:26 ; number:12 ; day:15 ; month:10 ; year:2024 ; pages:707-719 ; date:12.2024
Current atherosclerosis reports ; 26, Heft 12 (15.10.2024), 707-719, 12.2024
- Urheber
-
d’Aiello, Alessia
Filomia, Simone
Brecciaroli, Mattia
Sanna, Tommaso
Pedicino, Daniela
Liuzzo, Giovanna
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s11883-024-01241-3
- URN
-
urn:nbn:de:101:1-2501212103233.424895549474
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:24 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- d’Aiello, Alessia
- Filomia, Simone
- Brecciaroli, Mattia
- Sanna, Tommaso
- Pedicino, Daniela
- Liuzzo, Giovanna
- SpringerLink (Online service)
Ähnliche Objekte (12)
Targeting inflammatory pathways in axial spondyloarthritis
Inflammatory Chemokines in Atherosclerosis
Imaging of atherosclerosis, targeting LFA-1 on inflammatory cells with 111In-DANBIRT
Atherosclerosis is an inflammatory disease
Infection and atherosclerosis: TLR-dependent pathways
Targeting pan-essential pathways in cancer with cytotoxic chemotherapy: challenges and opportunities
Targeting Inflammatory Pathways by Flavonoids for Prevention and Treatment of Cancer
Targeting Inflammation in Atherosclerosis Using Colchicine
Targeting the chemokine network in atherosclerosis
Inflammatory and infectious basis of atherosclerosis
A systematic comparison of clinically viable nanomedicines targeting HMG-CoA reductase in inflammatory atherosclerosis
Targeting pro-inflammatory T cells as a novel therapeutic approach to potentially resolve atherosclerosis in humans
Targeting inflammatory pathways in axial spondyloarthritis
Inflammatory Chemokines in Atherosclerosis
Imaging of atherosclerosis, targeting LFA-1 on inflammatory cells with 111In-DANBIRT
Atherosclerosis is an inflammatory disease
Infection and atherosclerosis: TLR-dependent pathways
Targeting pan-essential pathways in cancer with cytotoxic chemotherapy: challenges and opportunities
Targeting Inflammatory Pathways by Flavonoids for Prevention and Treatment of Cancer
Targeting Inflammation in Atherosclerosis Using Colchicine
Targeting the chemokine network in atherosclerosis
Inflammatory and infectious basis of atherosclerosis
A systematic comparison of clinically viable nanomedicines targeting HMG-CoA reductase in inflammatory atherosclerosis
Targeting pro-inflammatory T cells as a novel therapeutic approach to potentially resolve atherosclerosis in humans
Targeting inflammatory pathways in axial spondyloarthritis
Inflammatory Chemokines in Atherosclerosis
Imaging of atherosclerosis, targeting LFA-1 on inflammatory cells with 111In-DANBIRT
Atherosclerosis is an inflammatory disease
Infection and atherosclerosis: TLR-dependent pathways
Targeting pan-essential pathways in cancer with cytotoxic chemotherapy: challenges and opportunities
Targeting Inflammatory Pathways by Flavonoids for Prevention and Treatment of Cancer
Targeting Inflammation in Atherosclerosis Using Colchicine
Targeting the chemokine network in atherosclerosis
Inflammatory and infectious basis of atherosclerosis
A systematic comparison of clinically viable nanomedicines targeting HMG-CoA reductase in inflammatory atherosclerosis